Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK-positive cell growth.

ABSTRACT: We used bisulfite conversion and Illumina sequencing to analyse miR-150 DNA methylation pattern lost in cells treated with decitabine, a demethylating agent, Crizotinib, an inhibitor of of ALK activity or siALK

ORGANISM(S): Homo sapiens

PROVIDER: GSE69836 | GEO | 2015/08/01

SECONDARY ACCESSION(S): PRJNA286887

REPOSITORIES: GEO